The gastrointestinal tract can release various peptides which are closely related to T2DM, such as glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This evidence concerns the gene GIP and type 2 diabetes mellitus.